Pelacho B, Luttun A, Aranguren XL, Verfaillie CM, Prosper F. Therapeutic potential of adult progenitor cells in cardiovascular disease. Expert Opin Biol Ther. 2007;7:1153-65. (Pubitemid 47307262)
Ruvinov E, Dvir T, Leor J, Cohen S. Myocardial repair: from salvage to tissue reconstruction. Expert Rev Cardiovasc Ther. 2008;6:669-86.
Vassalli G, Vanderheyden M, Renders F, Eeckhout E, Bartunek J. Bone marrow stem cell therapy for cardiac repair: challenges and perspectives. Minerva Cardioangiol. 2007;55: 659-67. (Pubitemid 350205685)
Pelus LM. Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand. Curr Opin Hematol. 2008;15:285-92.
Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A,et al. Randomised trial of fi lgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet. 1996;347:353-7.
Papayannopoulou T, Priestley GV, Nakamoto B, Zafi ropoulos V, Scott LM. Molecular pathways in bone marrow homing: dominant role of alpha(4)beta(1) over beta(2)-integrins and selectins. Blood. 2001;98:2403-11.
Cottler-Fox MH, Lapidot T, Petit I, Kollet O, DiPersio JF, Link D,et al. Stem cell mobilization. Hematol Am Soc Hematol Educ Program. 2003;419-37.
Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973-81.
Kim S, von Recum H. Endothelial stem cells and precursors for tissue engineering: cell source, differentiation, selection, and application. Tissue Eng Part B Rev. 2008;14:133-47.
Levesque JP, Winkler IG, Larsen SR, Rasko JE. Mobilization of bone marrow-derived progenitors. Handb Exp Pharmacol. 2007;3-36.
Delorme B, Charbord P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med. 2007;140:67-81.
He Q, Wan C, Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells. 2007;25:69-77.
L und TC, Tolar J, Orchard PJ. Granulocyte colony-stimulating factor mobilized CFU-F can be found in the peripheral blood but have limited expansion potential. Haematologica. 2008;93:908-12.
Wang Y, Ripa RS, Jorgensen E, Hesse B, Mortensen S,Kastrup J. Mobilization of haematopoie tic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease. Scand Cardiovasc J. 2007;41:397-404.
Abdel-Latif A, Bolli R, Zuba-Surma EK, Tleyjeh IM, Hornung CA, Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J. 2008;156:216-26.
Ripa RS, Kastrup J. G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction: a relevant treatment? Exp Hematol. 2008; 36:681-6.
Walrand S, Jamar F, de Jong M, Pauwels S. Evaluation of novel whole-body high-resolution rodent SPECT (Linoview) based on direct acquisition of linogram projections. J Nucl Med. 2005;46:1872-80.
Roelants V, Delgaudine M, de Leval L, Beguin Y, Vanovershelde J, Jamar F,et al. Evaluation of the novel high-resolution rodent Linoview SPECT for myocardial perfusion imaging of mice. Eur J Nucl Med Mol Imaging. 2007;S244.
Bungart B, Loeffl er M, Goris H, Dontje B, Diehl V, Nijhof W. Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol. 1990;76:174-9.
Varas F, Bernad A, Bueren JA. Granulocyte colony-stimulating factor mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice. Blood. 1996;88:2495-501.
Chiang KY, Lamb L, Clark J, Worthington-White D, Rich I, Henslee-Downey PJ. Assessment of G-CSF stimulated BM hematopoietic stem cells in normal donors. Cytotherapy. 2002;4:55-63.
Lucas D, Battista M, Shi PA, Isola L, Frenette PS. Mobilized hematopoietic stem cell yield depends on species-specifi c circadian timing. Cell Stem Cell. 2008;3:364-6.
Fibbe WE, Hamilton MS, Laterveer LL, Kibbelaar RE, Falkenburg JH, Visser JW,et al. Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells. J Immunol. 1992;148:417-21.
Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood. 2001;98:1289-97.
Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR,et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kitligand. Cell. 2002;109:625-37.
Yu X, Huang Y, Collin-Osdoby P, Osdoby P. Stromal cellderived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res. 2003;18:1404-18.
Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell. 2009;4:62-72.
Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR,et al. Human CD34- AC133- VEGFR-2- cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109-18.
Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML,et al. Endothelial outgrowth cells are not derived from CD133- cells or CD45- hematopoietic precursors. Arterioscler Thromb Vasc Biol. 2007;27:1572-9.
Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H,et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1 - 7.
Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F,et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc Natl Acad Sci USA. 2001;98:10344-9.
Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M,et al. Expression of VEGFR-2 and AC133 by circulating human CD34(- ) cells identifi es a population of functional endothelial precursors. Blood. 2000;95:952-8.
Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J,et al. Mobilized endothelial progenitor cells by granulocyte - macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular infl ammation after intravascular radiation. Circulation. 2003;108:2918-25.
Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G,et al. Isolation of mesenchymal stem cells from G-CSFmobilized human peripheral blood using fi brin microbeads. Bone Marrow Transplant. 2006;37:967-76.
Tatsumi K, Otani H, Sato D, Enoki C, Iwasaka T, Imamura H,et al. Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J. 2008;72:1351-8.
Cesselli D, Beltrami AP, Rigo S, Bergamin N, D A urizio F, Verardo R,et al. Multipotent progenitor cells are present in human peripheral blood. Circ Res. 2009;104:1225-34.
Liu ZJ, Zhuge Y, Velazquez OC. Traffi cking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106: 984-91.
Mansilla E, Marin GH, Drago H, Sturla F, Salas E, Gardiner C,et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the infl uence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc. 2006;38:967-9.
Zvaifl er NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA,et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2:477-88.
Sesti C, Hale SL, Lutzko C, Kloner RA. Granulocyte colonystimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol. 2005;46:1662-9.
Sugano Y, Anzai T, Yoshikawa T, Maekawa Y, Kohno T, Mahara K,et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res. 2005;65:446-56.
Ai G, Su Y, Yan G, Wang M, Liu X, Xu H,et al. [The experimental study of bone marrow mesenchymal stem cells on the repair of skin wound combined with local radiation injury]. Zhonghua Yi Xue Za Zhi. 2002;82:1632-6.
Lee CH, Moioli EK, Mao JJ. Fibroblastic differentiation of human mesenchymal stem cells using connective tissue growth factor. Conf Proc IEEE Eng Med Biol Soc. 2006;1: 775-8.
Arimura K, Inoue H, Kukita T, Matsushita K, Akimot M, Kawamata N,et al. Acute lung injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte- colony stimulating factor alone. Haematologica. 2005;90:ECR10.
Xu Q, Ming Z, Dart AM, Du XJ. Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol. 2007;34:499-507.
Moog R. Mobilization and harvesting of peripheral blood stem cells. Curr Stem Cell Res Ther. 2006;1:189-201.
Kang S, Yang Y, Li CJ, Gao R. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Clin Ther. 2007;29:2406-18.
de Kruijf EJ, van Pel M, Hagoort H, Kruysdijk D, Molineux G, Willemze R,et al. Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF. Hum Immunol. 2007;68:368-74.
